Sole Source CareDX AlloMap and AlloSure post heart transplant rejection surveillance tests

This Request for Quotation solicits for sole source CareDx AlloMap and AlloSure post heart transplant rejection surveillance testing services. The Department of Veterans Affairs seeks to procure AlloMap testing for approximately 30 patients per year and AlloSure testing for approximately 15 patients per year. The period of performance is a one-year base period starting March 1, 2022, with four one-year option periods to extend through February 28, 2027. Quotations are due by October 28, 2021. Pricing is requested for the base period and each option period, and services will be provided in accordance with the attached Performance Work Statement and Quality Assurance Surveillance Plan.

This opportunity is set aside for total small businesses. The services will be provided by CareDx, Inc. and performed in Palo Alto, California. The RFQ provides pricing for the one-year base period as well as four one-year option periods, with testing for approximately 30 patients per year under AlloMap and 15 patients per year under AlloSure.